The 45 references in paper Yu. Zhitnukhin L., I. Abdurasulova N., E. Tarasova A., D. Sokolov I., T. Novikova A., Ю. Житнухин Л., И. Абдурасулова Н., Е. Тарасова А., Д. Соколов И., Т. Новикова А. (2014) “ОСОБЕННОСТИ ДИНАМИКИ ЦИРКУЛИРУЮЩИХ И ЭКСПРЕССИРУЕМЫХ ЦИТОКИНОВ ПРИ ИНДУКЦИИ ЭКСПЕРИМЕНТАЛЬНОГО АЛЛЕРГИЧЕСКОГО ЭНЦЕФАЛОМИЕЛИТА // DYNAMICS OF CIRCULATING AND EXPRESSED CYTOKINES UPON INDUCTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS” / spz:neicon:mimmun:y:2008:i:3:p:193-202

1
Абдурасулова И.Н., Житнухин Ю.Л., Тарасова Е.А., Клименко В.М. Экспрессия мРНК цитокинов в селезенке и спинном мозге крыс с различной тяжестью ЭАЭ // Мед. иммунология. – 2004. – Т. 6. – No 1-2. – С. 37-46.
(check this in PDF content)
2
Гусев Е.И., Демина Т.Д., Бойко А.Н. Рассеянный склероз. – М., 1997. – 463 с.
(check this in PDF content)
3
Демина Т.Л., Бойко А.Н., Оганезов В.К. Участие фактора некроза опухолей-альфа в иммунорегуляции при хронически-прогрессирующих формах рассеянного склероза // Иммунология. – 1991. – No 4. – С. 40-44.
(check this in PDF content)
4
Житнухин Ю.Л., Никитина Е.Ю., Фрейдлин И.С. Развитие активно индуцированного экспериментального аллергического энцефаломиелита в условиях введения пентоксифиллина // Нейроиммунология, нейроинфекции, демиелинизация. – СПб., 1997. – С. 22-25.
(check this in PDF content)
5
Тотолян А.А., Фрейдлин И.С. Клетки иммунной системы. – СПб.: Наука, 2000. – 231 с.
(check this in PDF content)
6
Фрейдлин И.С. Иммунная система и ее дефекты. – СПб.: НТФФ «Полисан», 1998. – 111 с.
(check this in PDF content)
7
Agnello D., Villa P., Ghezzi P. Increased tumor necrosis factor and interleukin-6 production in the central nervous system of interleukin-10-deficient mice // Brain Res. – 2000. – Vol. 869, N 1-2. – P. 241-243.
(check this in PDF content)
8
Almeras L., Meresse B., Seze J., De Lefranc D., Dubucquoi S., Fajardy I., Vermersch P., Prin L. Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression // Eur. Cytokine Netw. – 2002. – Vol. 13, N 2. – P. 200-206.
(check this in PDF content)
9
Baarsch M.J., Wannemuehler V.J., Molitor T.W., Murtangh M.P. Detection of tumor necrosis factor-α from porcine alveolar macrophages using an L-929 fibroblast bioassay // J. Immunol. method. – 1991. – Vol. 140. – P. 15-22.
(check this in PDF content)
10
Bachmann R., Eugster H.P., Frei K., Fontana A., Lassmann H. Impairment of TNFreceptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice // Am. J. Pathol. – 1999. – Vol. 154, N 5. – P. 1417-1422.
(check this in PDF content)
11
Balkwill F., Osborne R., Burke F., Naylor S., Talbot D., Durbin H., Tavernier J., Fiers W. Evidence for tumor necrosis factor/cachectin production in cancer // Lancet. – 1987. – Vol. 2. – P. 1229-1232.
(check this in PDF content)
12
Begolka W.S., Vanderlugt C.L., Rahbe S.M., Miller S.D. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis // J. Immunol. – 1998. – Vol. 161, N 8. – P. 4437-4446.
(check this in PDF content)
13
Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4 deficient and transgenic mice // J. Immunol. – 1998. – Vol. 161, N 7. – P. 3299-3306.
(check this in PDF content)
14
Beutler B., Cerami A. Cachectin: more than a tumor necrosis factor // N. Engl. J. Med. – 1987. – Vol. 316. – P. 379-385.
(check this in PDF content)
15
Cannella B., Raine C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions // Ann. Neurol. – 1995. – Vol. 37, N 4. – P. 424-435.
(check this in PDF content)
16
Clerici M., Saresella M., Trabattoni D., Speciale L., Fossati S., Ruzzante S., Cavaretta R., Filippi M., Caputo D., Ferrante P. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease // J. Neuroimmunol. – 2001. – Vol. 121, N 1-2. – P. 88-101.
(check this in PDF content)
17
Crisi G.M., Santambrogio L., Hochwald G.M., Smith S.R., Carlino J.A., Thorbecke G.J. Staphylococcal enterotoxin B and tumor-necrosis factor-alfa-induced relapses of experimental allergic encephalomyelitic: protection by transforming growth factor-beta and interleukin-10 // Eur. J. Immunol. – 1995. – Vol. 25, N 11. – P. 3035-3040.
(check this in PDF content)
18
Cua D.J., Groux H., Hinton D.R., Stohlman S.A., Coffman R.L. Transgenic interleukin 10 prevents induction of experimental allergic encephalomyelitis // J. Exp. Med. – 1999. – Vol. 189, N 6. – P. 1005-1010.
(check this in PDF content)
19
Jong B.A., Schrijver H.M., Huizinga T.W., Bollen E.L., Polman C.H., Uitdehaag B.M., Kersbergen M.C., Sturk A., Westendorp R.G. Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis // Ann. Neurol. – 2000. – Vol. 48, N 4. – P. 641-646.
(check this in PDF content)
20
Diab A., Zhu J., Xiao B.G., Mustafa M., Link H. High IL-6 and IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats // J. Neuropatol. Exp. Neurol. – 1997. – Vol. 56, N 6. – P. 641-650.
(check this in PDF content)
21
Furuya T., Joe B., Salstrom J.L., Hashiramoto A., Dobbins D.E., Wilder R.L., Remmers E.F. Polymorphisms of the tumor necrosis factor alpha locus among autoimmune disease susceptible and resistant inbred rat strains // Genes Immun. – 2001. – Vol. 2, N 4. – P. 229-232.
(check this in PDF content)
22
Hopkins S.J., Rothwell N.J. Cytokines and the nervous system: expression and recognition // Trends Neurosci. – 1995. – Vol. 18, N 2. – P. 83-88.
(check this in PDF content)
23
Issazadeh S., Lorentzen J.C., Mustafa M., Hojeberg B., Mussener A., Olsson T. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression оf interleukin-10 and transforming growth factor-beta // J. Neuroimmunol. – 1996. – Vol. 69, N 1-2. – P. 103-115.
(check this in PDF content)
24
Jacobs C.A., Baker P.E., Roux E.R., Picha K.S., Toivola B., Waugh S., Kennedy M.K. Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor // J. Immunol. – 1991. – V. 146, N 9. – P. 2983-2989.
(check this in PDF content)
25
Jander S., Pohl J., D’Urso D., Gillen C., Stoll G. Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system // Am. J. Pathol. – 1998. – Vol. 152, N 4. – P. 975-982.
(check this in PDF content)
26
Kassiotis G., Kollias G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination // J. Exp. Med. – 2001. – Vol. 193, N 4. – P. 427-434.
(check this in PDF content)
27
Kraus J., Kuehne B.S., Tofighi J., Frielinghaus P., Stolz E., Blaes F., Laske C., Engelhardt B., Traupe H., Kaps M., Oschmann P. Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis // Acta Neurol. Scand. – 2002. – Vol. 105, N 4. – P. 300-308.
(check this in PDF content)
28
Kuroda Y., Shimamoto Y. Human tumor necrosis factor – alpha augments experimental autoimmune encephalomyelitis in rats // J. Neuroimmunol. – 1991. – Vol. 34, N 2-3. – P. 159-164.
(check this in PDF content)
29
Mikova O., Yakimova R., Bosmans E., Kenis G., Maes M. Increased serum tumor necrosis factor alpha concentration in major depression and multiple sclerosis // Eur. Neuropsychopharmacol. – 2001. – Vol. 11, N 3. – P. 203-208.
(check this in PDF content)
30
Okuda Y., Sacoda S., Bernard C.C., Yanagihara T. The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system // J. Interferon Cytokine Res. – 1998. – Vol. 18, N 6. – P. 415-421.
(check this in PDF content)
31
Oliff A., Defeo-Jones D., Boyer M., Martinez D., Kiefer D., Vuocolo G., Wolfe A., Socher S.H. Tumors secreting human TNF/cachectin induce cachexia in mice // Cell. – 1987. – Vol. 50. – P. 555-563.
(check this in PDF content)
32
Olsson T. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis // Neurology. – 1995. – Vol. 45, N 6. – P. 11-15.
(check this in PDF content)
33
Ozenci V., Kouwenhoven M., Huang Y.M., Kivisakk P., Link H. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNFalpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment // Clin. Exp. Immunol. – 2000. – Vol. 120, N 1. – P. 147-153.
(check this in PDF content)
34
Perrella O., Sbreglia C., Perrella M., Spetrini G., Gorga F., Pezzella M., Perrella A., Atripaldi L., Carrieri P. Interleukin-10 and tumor necrosis factor-alpha: model of immunomodulation in multiple sclerosis // Neurol Res. – 2006. – Vol. 28, N 2. – P. 193-195.
(check this in PDF content)
35
Petereit H.F., Pukrop R., Fazekas F., Bamborschke S.U., Ropele S., Kolmel H.W., Merkelbach S., Japp G., Jongen P.J., Hartung H.P., Hommes O.R. Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis // J. Neurol. Sci. – 2003. – Vol. 206, N 2. – P. 209-214.
(check this in PDF content)
36
Bott O., Fleischer B., Cash E. Inerleukin- 10 prevents experimental allergic encephalomyelitis in rats // Eur. J. Immunol. – 1994. – Vol. 24. – P. 1434-1440.
(check this in PDF content)
37
Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis // J. Exp. Med. – 1990. – Vol. 172. – P. 1193-1200.
(check this in PDF content)
38
Sambrook J., Fritsch F., Maniatis T. Molecular cloning. A laboratory manual // Gold Spring Harbor Laboratory. – 2nd ed. – 1989. – Vol. 2. – P. 14.18-14.19.
(check this in PDF content)
39
Samoilova E.B., Horton J.L., Chen Y. Accelaration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery // Cell Immunol. – 1998. – Vol. 188, N 2. – P. 118-124.
(check this in PDF content)
40
Selmaj K.W., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro // Ann. Neurol. – 1988. – Vol. 23, N 4. – P. 339-346.
(check this in PDF content)
41
Selmaj K.W., Raine C.S. Experimental autoimmune encephalomyelitis: immunotherapy with antitumor necrosis factor antibodies and soluble tumor necrosis factor receptor // Neurol. – 1995. – Vol. 45, N 6. – P. 44-49.
(check this in PDF content)
42
Sharief M.K., Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis // N. Engl. J. Med. – 1991. – Vol. 326, N 4. – P. 467-472.
(check this in PDF content)
43
Stefferl A., Linington C., Holsboer F., Reul J.M. Susceptibility and resistance to EAE: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat // Endocrinol. – 1999. – Vol. 140, N 11. – P. 4932-4938.
(check this in PDF content)
44
Tanuma N., Kojima T., Shin T., Aikawa Y., Ko hji T., Ishihara Y., Matsumoto Y. Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis // J. Neuroimmunol. – 1997. – Vol. 73, N 1-2. – P. 197-206.
(check this in PDF content)
45
Xiao B.G., Bai X.F., Zhang G.X., Link H. Supression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats // J. Neuroimmunol. – 1998. – Vol. 84, N 2. – P. 230-237.
(check this in PDF content)